OrbiMed’s Mural Oncology MURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-588,800
Closed -$1.22M 122
2025
Q3
$1.22M Hold
588,800
0.03% 101
2025
Q2
$1.45M Buy
+588,800
New +$1.39M 0.04% 88

OrbiMed's MURA Position: Q4 2025 in Review

OrbiMed sold out of Mural Oncology (MURA) in Q4 2025, closing a stake of 588,800 shares — an estimated $1.22M sold.

OrbiMed first reported a position in MURA in Q2 2025 and held it in 2 quarters. The position peaked at $1.45M in Q2 2025. 0 funds tracked by Wall St. Rank hold MURA as of Q4 2025.

  • OrbiMed reported no remaining Mural Oncology position as of Q4 2025 after selling out during the quarter.
  • OrbiMed sold 588,800 Mural Oncology shares in Q4 2025, an estimated $1.22M.
  • OrbiMed first reported a position in Mural Oncology in Q2 2025 and held it in 2 quarters.
  • OrbiMed's Mural Oncology position peaked at $1.45M in Q2 2025.
  • 0 funds tracked by Wall St. Rank held Mural Oncology as of Q4 2025.

Based on OrbiMed's 13F filing for Q4 2025, filed 17 Feb 2026.